These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 200923)

  • 1. Enzyme replacement therapy in Gaucher's disease: preliminary clinical trial of a new enzyme preparation.
    Beutler E; Dale GL; Guinto DE; Kuhl W
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4620-3. PubMed ID: 200923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme replacement therapy in Gaucher's disease: large-scale purification of glucocerebrosidase suitable for human administration.
    Furbish FS; Blair HE; Shiloach J; Pentchev PG; Brady RO
    Proc Natl Acad Sci U S A; 1977 Aug; 74(8):3560-3. PubMed ID: 269414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme replacement therapy in Gaucher's disease: a rapid, high-yield method for purification of glucocerebrosidase.
    Dale GL; Beutler E
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4672-4. PubMed ID: 1070017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease.
    Barton NW; Brady RO; Dambrosia JM; Di Bisceglie AM; Doppelt SH; Hill SC; Mankin HJ; Murray GJ; Parker RI; Argoff CE
    N Engl J Med; 1991 May; 324(21):1464-70. PubMed ID: 2023606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease.
    Barton NW; Furbish FS; Murray GJ; Garfield M; Brady RO
    Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1913-6. PubMed ID: 2308952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Gaucher's disease with liposome-entrapped glucocerebroside: beta-glucosidase.
    Belchetz PE; Crawley JC; Braidman IP; Gregoriadis G
    Lancet; 1977 Jul; 2(8029):116-7. PubMed ID: 69198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme replacement therapy in Gaucher's and Fabry's disease.
    Pentchev PG
    Ann Clin Lab Sci; 1977; 7(3):251-3. PubMed ID: 404951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of glucocerebrosidase into Gaucher's disease monocytes in vitro.
    Dale GL; Kuhl W; Beutler E
    Proc Natl Acad Sci U S A; 1979 Jan; 76(1):473-5. PubMed ID: 284362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked clinical and histologic improvement in a patient with type-1 Gaucher's disease following long-term glucocerebroside substitution. A case report and review of current diagnosis and management.
    Heukamp LC; Schröder DW; Plassmann D; Homann J; Büttner R
    Pathol Res Pract; 2003; 199(3):159-63. PubMed ID: 12812317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospects for enzyme replacement therapy in Gaucher disease.
    Brady RO; Barranger JA; Furbish FS; Stowens DW; Ginns EI
    Prog Clin Biol Res; 1982; 95():669-80. PubMed ID: 7122643
    [No Abstract]   [Full Text] [Related]  

  • 11. Replacement therapy for inherited enzyme deficiency. Use of purified glucocerebrosidase in Gaucher's disease.
    Brady RO; Pentchev PG; Gal AE; Hibbert SR; Dekaban AS
    N Engl J Med; 1974 Nov; 291(19):989-93. PubMed ID: 4415565
    [No Abstract]   [Full Text] [Related]  

  • 12. Marked elevation of serum angiotension-converting enzyme and hepatic fibrosis containing long-spacing collagen fibrils in type 2 acute neuronopathic Gaucher's disease.
    Silverstein E; Friedland J; Vuletin JC
    Am J Clin Pathol; 1978 Apr; 69(4):467-71. PubMed ID: 206129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Response criteria for enzyme substitution in Gaucher disease].
    Berthold F; Sieverts H; Benz-Bohm G; Landwehr P; Harzer K
    Monatsschr Kinderheilkd; 1992 Oct; 140(10):740-4. PubMed ID: 1331780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gaucher disease: a century of delineation and research. Enzyme replacement therapy: model and clinical studies.
    Beutler E; Dale GL
    Prog Clin Biol Res; 1982; 95():703-16. PubMed ID: 7122644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Status of enzyme replacement therapy for Gaucher disease.
    Brady RO; Barranger JA; Gal AE; Pentchev PG; Furbish FS
    Birth Defects Orig Artic Ser; 1980; 16(1):361-8. PubMed ID: 7004519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gaucher's disease and enzyme replacement therapy].
    Cornu F
    Ann Pharm Fr; 1998; 56(3):102-7. PubMed ID: 9770016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taliglucerase alfa for the treatment of Gaucher's disease.
    Haddley K
    Drugs Today (Barc); 2012 Aug; 48(8):525-32. PubMed ID: 22916340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement In Symptoms Of Gaucher's Disease By Enzyme Replacement Therapy.
    Mazher W; Ali J; Abubakar S; Basar S; Murtaza G
    J Ayub Med Coll Abbottabad; 2018; 30(3):479-481. PubMed ID: 30465391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal acid-phosphatase and angiotensin converting enzyme activities in serum of a patient with Gaucher's disease.
    Daniels LB; Robinson DB; Glew RH; Wylin RF
    Clin Chem; 1981 Oct; 27(10):1782-3. PubMed ID: 6269780
    [No Abstract]   [Full Text] [Related]  

  • 20. Elevation of serum angiotensin-converting enzyme in Gaucher's disease.
    Lieberman J; Beutler E
    N Engl J Med; 1976 Jun; 294(26):1442-4. PubMed ID: 179000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.